Validation of the Korean Confusion Assessment Method for the Intensive Care Unit (CAM-ICU)

This study has been completed.
Sponsor:
Information provided by:
Seoul National University Hospital
ClinicalTrials.gov Identifier:
NCT00998387
First received: October 16, 2009
Last updated: October 17, 2009
Last verified: October 2009
  Purpose

The purpose of this study is to translate and validate the CAM-ICU for use in the Korean ICU setting.


Condition
Critical Care

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Translation and Validation of the Korean Version of Confusion Assessment Method for the Intensive Care Unit

Resource links provided by NLM:


Further study details as provided by Seoul National University Hospital:

Primary Outcome Measures:
  • Interrater reliability of Korean CAM-ICU [ Time Frame: after completion of study ] [ Designated as safety issue: No ]
  • Sensitivity of Korean CAM-ICU for diagnosing ICU delirium [ Time Frame: after completion of study ] [ Designated as safety issue: No ]
  • Specificity of Korean CAM-ICU for diagnosing ICU delirium [ Time Frame: after completion of study ] [ Designated as safety issue: No ]

Enrollment: 63
Study Start Date: July 2008
Study Completion Date: March 2009
Primary Completion Date: March 2009 (Final data collection date for primary outcome measure)
Groups/Cohorts
medical ICU
admitted to medical ICU at Seoul National University Hospital longer than 24 hours

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients admitted to medical ICU at Seoul National University Hospital longer than 24 hours

Criteria

Inclusion Criteria:

  • older than 18 years
  • admitted to medical ICU at Seoul National University Hospital longer than 24 hours

Exclusion Criteria:

  • comatose or moribund state throughout the study period
  • preexisting neurologic problem
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00998387

Locations
Korea, Republic of
Seoul National University Hospital
Seoul, Korea, Republic of, 110-744
Sponsors and Collaborators
Seoul National University Hospital
Investigators
Principal Investigator: Sang Min Lee, MD Seoul National University Hospital
  More Information

No publications provided

Responsible Party: Sang Min Lee M.D, Seoul National University Hospital
ClinicalTrials.gov Identifier: NCT00998387     History of Changes
Other Study ID Numbers: 0803-058-239
Study First Received: October 16, 2009
Last Updated: October 17, 2009
Health Authority: Korea: Institutional Review Board

ClinicalTrials.gov processed this record on October 01, 2014